CN · Field Sheet
FIELD SHEET — SEA BUCKTHORN MFI-SEABUC-20261023-FS
Survey index / SEA BUCKTHORN

Sea Buckthorn.

Hippophae rhamnoides
Hippophae berry; omega-7, skin-mucosal and lipid literature.
SEALED MFI-SEABUC-20261023-FS · RELEASED 2026-10-23
SHEET FINGERPRINTMFI-SEABUC-20261023-FS
257INCLUDED
2,145EXCLUDED
29DUPLICATE
115NON-TRANSFERABLE
2OUT OF CUTOFF
Survey totalsScroll ↓
2,548records surveyed
257studies
31claims graded
86observations
8,472graph nodes

Claim records

2 shown · bounded preview
RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-ac5d7eb2884f903aGRADE VERY_LOW
sea buckthorn constituents — inflammation
direction BENEFIT · dose UNSPECIFIED · duration 10 days; 14 weeks
Grade basis — weakest-link ceilings
VERY_LOWdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
13bound studies
Bound studies (4 shown of 13)
STU-1896a6454bfd9d51
ANIMAL · ANIMAL · 2024 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-3c2534987b578ce2
ANIMAL · ANIMAL · 2026 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-59ca0a37a5e34fd5
ANIMAL · ANIMAL · 2024 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-5bfcdfb84fcb2125
ANIMAL · ANIMAL · 2025 · RoB INSUFFICIENT_INFORMATION
5 endpoints
Quantitative observations
observation p < 0.05 · validated
observation p < 0.05 | p < 0.05 · failed extraction
observation 14 weeks · failed extraction
Opposition screen
SCREEN · 20 candidates considered · 3 bound as opposing
SYNTHESIS SYN-a6403256ce4d38 — outcome QUALITATIVE_ONLY · BENEFIT ×13 · not_assessed_quantitatively · 13 members
PROVENANCE → epmc:38992530, epmc:41806621, oax:https://openalex.org/W4395464786 · PKG ba3f09489d81281d…
CLAIM · CLM-6cdbb2035020277fGRADE VERY_LOW
sea buckthorn constituents — antioxidant
direction BENEFIT · dose 16.282 mg · duration UNSPECIFIED
Grade basis — weakest-link ceilings
VERY_LOWdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
9bound studies
Bound studies (4 shown of 9)
STU-4bd1a84bf540738d
IN_VITRO · IN_VITRO · 2025 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-59ca0a37a5e34fd5
ANIMAL · ANIMAL · 2024 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-5afe3db69dc29738
ANIMAL · ANIMAL · 2021 · RoB INSUFFICIENT_INFORMATION
1 endpoints
STU-5bfcdfb84fcb2125
ANIMAL · ANIMAL · 2025 · RoB INSUFFICIENT_INFORMATION
5 endpoints
Quantitative observations
observation increased by 57.97 % · unvalidated
observation p < 0.0007 · validated
observation 16.282 mg · validated
Opposition screen
SCREEN · 18 candidates considered · 3 bound as opposing
SYNTHESIS SYN-4a79ff57e9fdea — outcome QUALITATIVE_ONLY · BENEFIT ×9 · not_assessed_quantitatively · 9 members
PROVENANCE → epmc:40947220, oax:https://openalex.org/W4395464786, epmc:34667227 · PKG ba3f09489d81281d…
Bounded preview — representative records only. The full release ships 31 claims and 86 observations.